Bryan Kay
Artivion granted FDA humanitarian device exemption for the AMDS hybrid prosthesis
Artivion recently announced that the Food and Drug Administration (FDA) has granted a humanitarian device exemption (HDE) for use of the AMDS hybrid prosthesis...
Innovation in vascular surgery: Balancing progress with patient safety
A debate at this year's European Society for Vascular Surgery (ESVS 2024) annual meeting (Sept. 24–27) in Kraków, Poland, centered on innovation in vascular...
VASC.AI: Canadian vascular surgery researchers develop vascular-specific bot aimed at aiding...
The advent of large language models such as ChatGPT (Open AI) has left little of the world untouched—and a quintet of University of Toronto...
Service: Giving back
Pioneering American Venous Forum (AVF) and Eastern Vascular Society (EVS) efforts aimed at breaking down barriers to care and educating patients in economically challenged...
Novel measure suggests 20% of elective carotid revascularizations fail to achieve...
One in five patients failed to achieve a textbook outcome after undergoing carotid endarterectomy (CEA), transcarotid artery revascularization (TCAR) or transfemoral carotid artery stenting...
Bentley announces first-in-human implantation of BeFlared bridging stent
Bentley has announced the successful first-in-human implantation of its recently CE-certified BeFlared stent graft system, which the company states is the world’s first dedicated...
WAVE trial AVG cohort also benefits at six months with Wrapsody
Newly released six-month results from single-arm arteriovenous graft (AVG) cohort in the WAVE (Wrapsody arteriovenous access efficacy) trial showed target lesion and access circuit...
BEST-CLI: Trial results endure in analysis of patients who presented with...
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of...
Rates of MAE and reintervention following F/BEVAR remain ‘stable,’ Aortic Research...
Latest study out of consortium details trends and outcomes after F/BEVAR procedures carried out over an eight-year period under consortium of 10 physician-sponsored IDEs.
Despite...
Vascular Specialist–November 2024
In this issue:
Service: Giving back—The Eastern Vascular Society (EVS) and American Venous Forum (AVF) pioneer vascular days of service in the community
...
Endoscopic vein harvest under the microscope
Conflicting results open fresh debate around effect of vein harvesting technique on long-term patency of lower extremity bypass grafts.
Two separate analyses that looked at...
The Japanese concept of ikigai and how mentorship might help specialty...
The Japanese concept of ikigai, or an individual’s reason for being, underpinned the message behind a fresh call for mentorship in vascular surgery and...
NESVS 2024: Simons becomes first woman president of New England Society...
Jessica P. Simons, MD, has become the 2024–25 president of the New England Society for Vascular Surgery (NESVS). She is the first woman to...
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH...
Michael Conte, MD, recently used his 2024 Veith Lecture to call on young vascular surgeons on the peripheral arterial disease (PAD) frontlines to drive...
CLOUT registry: Interim two-year rates of PTS ‘significantly lower’ than those...
Rates of post-thrombotic syndrome (PTS) among deep vein thrombosis (DVT) patients treated with the ClotTriever thrombectomy system (Inari Medical) who are logged in the...